Market Currents
Jefferies lifts it price target on Jazz Pharmaceuticals (JAZZ) to $64 from $56 on its belief...
-
Thursday, March 1, 2012, 7:13 AM ETJefferies lifts it price target on Jazz Pharmaceuticals (JAZZ) to $64 from $56 on its belief that the firm can beat its own guidance with its reconfigured sales structure. Analysts also raise their EPS estimates for Jazz for FY12 and FY13 by $0.04 and $0.73, respectively.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
